GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evogene Ltd (XTAE:EVGN) » Definitions » Cyclically Adjusted Book per Share

Evogene (XTAE:EVGN) Cyclically Adjusted Book per Share : ₪88.90 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Evogene Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Evogene's adjusted book value per share for the three months ended in Dec. 2024 was ₪-0.807. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₪88.90 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Evogene's average Cyclically Adjusted Book Growth Rate was -18.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-04-27), Evogene's current stock price is ₪3.89. Evogene's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was ₪88.90. Evogene's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Evogene was 0.40. The lowest was 0.04. And the median was 0.22.


Evogene Cyclically Adjusted Book per Share Historical Data

The historical data trend for Evogene's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evogene Cyclically Adjusted Book per Share Chart

Evogene Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 118.38 108.76 88.90

Evogene Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.76 104.95 99.81 94.40 88.90

Competitive Comparison of Evogene's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Evogene's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evogene's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evogene's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Evogene's Cyclically Adjusted PB Ratio falls into.


;
;

Evogene Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Evogene's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.807/133.1571*133.1571
=-0.807

Current CPI (Dec. 2024) = 133.1571.

Evogene Quarterly Data

Book Value per Share CPI Adj_Book
201503 162.464 99.621 217.155
201506 157.513 100.684 208.315
201509 154.283 100.392 204.638
201512 148.031 99.792 197.524
201603 144.357 100.470 191.322
201606 139.106 101.688 182.155
201609 132.780 101.861 173.576
201612 124.151 101.863 162.293
201703 117.793 102.862 152.485
201706 111.655 103.349 143.859
201709 105.561 104.136 134.980
201712 97.642 104.011 125.003
201803 90.561 105.290 114.530
201806 84.377 106.317 105.678
201809 78.113 106.507 97.659
201812 70.444 105.998 88.493
201903 65.482 107.251 81.299
201906 59.938 108.070 73.852
201909 78.941 108.329 97.033
201912 70.572 108.420 86.674
202003 61.891 108.902 75.676
202006 55.961 108.767 68.510
202009 51.446 109.815 62.381
202012 46.873 109.897 56.794
202103 64.155 111.754 76.442
202106 59.242 114.631 68.816
202109 53.438 115.734 61.483
202112 47.229 117.630 53.463
202203 40.060 121.301 43.976
202206 32.501 125.017 34.617
202209 26.883 125.227 28.586
202212 24.532 125.222 26.087
202303 19.234 127.348 20.111
202306 12.411 128.729 12.838
202309 13.270 129.860 13.607
202312 8.636 129.419 8.885
202403 5.934 131.776 5.996
202406 2.181 132.554 2.191
202409 -2.317 133.029 -2.319
202412 -0.807 133.157 -0.807

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Evogene  (XTAE:EVGN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Evogene's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.89/88.90
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Evogene was 0.40. The lowest was 0.04. And the median was 0.22.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Evogene Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Evogene's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Evogene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evogene Ltd (XTAE:EVGN) » Definitions » Cyclically Adjusted Book per Share
Traded in Other Exchanges
Address
13 Gad Feinstein Street, Park Rehovot, Ness Ziona, Rehovot, ISR, 7638517
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.